• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G filed by Scorpius Holdings Inc.

    9/6/24 4:01:41 PM ET
    $SCPX
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $SCPX alert in real time by email
    SC 13G 1 tm2423543d1_sc13g.htm SC 13G

     

     

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    SCHEDULE 13G

     

    (Rule 13d-102)

     

    Under the Securities Exchange Act of 1934

    (Amendment No.__)*

     

    Scorpius Holdings, Inc.

    (Name of Issuer)

     

    Common Stock, $0.0002 par value per share

    (Title of Class of Securities)

     

    42237K409

    (CUSIP Number)

     

    August 20, 2024

    (Date of Event Which Requires Filing of this Statement)

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

     

      ¨ Rule 13d-1(b)
         
      x Rule 13d-1(c)
         
      ¨ Rule 13d-1(d)

     

    * The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

     

    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     

     

     

    CUSIP No. 42237K409 Schedule 13G Page 2 of 5 Pages

     

    1.

    Names of Reporting Persons

     

    Ramnarain Joseph Jaigobind

    2.

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

    (See Instructions)

    (a) ¨

    (b) ¨

    3.

    SEC Use Only 

     

    4.

    Citizenship or Place of Organization

     

    United States

     

    NUMBER OF

    SHARES

    BENEFICIALLY

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

    5.

    Sole Voting Power

     

    309,034

    6.

    Shared Voting Power

     

    0

    7.

    Sole Dispositive Power

     

    309,034

    8.

    Shared Dispositive Power

     

    0

    9.

    Aggregate Amount Beneficially Owned by Each Reporting Person

     

    309,034

    10.

    Check if the Aggregate Amount in Row (9) Excludes Certain Shares

    (See Instructions)

    ¨

    11.

    Percent of Class Represented by Amount in Row (9)

     

    9.13%(1)

    12.

    Type of Reporting Person (See Instructions)

     

    IN

     

    (1) Based on of 3,384,268 shares of common stock, $0.0002 par value per share, of Scorpius Holdings, Inc. (the “Issuer”), issued and outstanding as of September 3, 2024, as reported by the Issuer to the Reporting Person.

     

     

     

     

    CUSIP No. 42237K409 Schedule 13G Page 3 of 5 Pages

     

    Item 1.  
       
    (a) Name of Issuer: Scorpius Holdings, Inc.
       
    (b) Address of Issuer’s Principal Executive Offices: 627 Davis Drive, Suite 300, Morrisville, NC 27560
       
    Item 2.  
       
    (a) Name of Person Filing: Ramnarain Joseph Jaigobind
       
    (b) Address of Principal Offices or, if None, Residence: c/o ThinkEquity LLC, 17 State Street,  41st Floor, New York, NY 10004
       
    (c)  Citizenship: United States
       
    (d)  Title of Class of Securities: common stock, $0.0002 par value per share (“Common Stock”)
       
    (e) CUSIP Number: 42237K409
       
    Item 3. If the Statement is being filed pursuant to Rule 13d-1(b) or 13d-2(b) or (c), check whether the filing person is a:
       
      Not applicable.
       
    Item 4. Ownership.

     

    (a) Amount beneficially owned:
       
      As of September 6, 2024, the Reporting Person beneficially owned 309,034 shares of Common Stock, which he holds directly.
       
    (b) Percent of class:
       
      The shares of Common Stock beneficially owned by the Reporting Person represented 9.13% of the shares of Common Stock as of September 6, 2024, based on 3,384,268 shares of Common Stock issued and outstanding as of September 3, 2024, as reported by the Issuer to the Reporting Person.
       
    (c) Number of shares as to which such person has:
       
    (i) Sole power to vote or direct the vote: 309,034 shares of Common Stock
       
    (ii) Shared power to vote or direct the vote: 0
       
    (iii) Sole power to dispose or to direct the disposition of: 309,034 shares of Common Stock
       
    (iv) Shared power to dispose or to direct the disposition of: 0

     

     

     

     

    CUSIP No. 42237K409 Schedule 13G Page 4 of 5 Pages

     

    Item 5. Ownership of Five Percent or Less of a Class.
       
      Not applicable.
       
    Item 6. Ownership of More than Five Percent on Behalf of Another Person.
       
      Not applicable.
       
    Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
       
      Not applicable.
       
    Item 8. Identification and Classification of Members of the Group.
       
      Not applicable.
       
    Item 9. Notice of Dissolution of Group.
       
      Not applicable.
       
    Item 10. Certification.
       
      By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

     

     

     

     

    CUSIP No. 42237K409 Schedule 13G Page 5 of 5 Pages

     

    SIGNATURE

     

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     

    September 6, 2024  
       
      /s/ Ramnarain Joseph Jaigobind
      RAMNARAIN JOSEPH JAIGOBIND

     

     

     

    Get the next $SCPX alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $SCPX

    DatePrice TargetRatingAnalyst
    More analyst ratings